Trial
NCT04543916
Venetoclax and Irinotecan in Relapsed/Refractory SCLC
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Virginia Commonwealth University
Collaborators
AbbVie
Condition
Relapsed Small Cell Lung Cancer
Intervention
Venetoclax 50 MG
Why stopped
AbbVie decided to stop trial involving Venetoclax for safety measures needed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-03